From 36 tubotympanic CSOM patients, we found 8 (22.22%) patients with MBL deficiency (MBL level < 100 ng/ml [16]), while no deficiency was found in the control group. This evidence concerns the gene MBL2 and hyperinsulinemic hypoglycemia, familial, 4.